301015 百洋医药
已收盘 08-16 15:00:00
资讯
新帖
简况
百洋医药新提交2件商标注册申请
证券之星 · 08-17 13:15
百洋医药新提交2件商标注册申请
百洋医药最新公告:拟5900万元参设廊坊临空百洋股权投资基金
证券之星 · 08-08
百洋医药最新公告:拟5900万元参设廊坊临空百洋股权投资基金
百洋医药(301015.SZ)拟出资5900万元入伙廊坊临空百洋股权投资基金
智通财经 · 08-08
百洋医药(301015.SZ)拟出资5900万元入伙廊坊临空百洋股权投资基金
华源证券7月31日发布研报称,给予百洋医药(301015.SZ)买入评级。评级理由主要包括:1)迪巧焕发新活力,院外业务潜力可期;
智通财经 · 07-31
华源证券7月31日发布研报称,给予百洋医药(301015.SZ)买入评级。评级理由主要包括:1)迪巧焕发新活力,院外业务潜力可期;
华源证券:给予百洋医药买入评级
证券之星 · 07-31
华源证券:给予百洋医药买入评级
7月31日百洋医药涨6.18%,安信医药健康股票A基金重仓该股
证券之星 · 07-31
7月31日百洋医药涨6.18%,安信医药健康股票A基金重仓该股
百洋医药涨6.18%,天风证券二个月前给出“买入”评级
证券之星 · 07-31
百洋医药涨6.18%,天风证券二个月前给出“买入”评级
百洋医药(301015)2名股东合计质押3500万股,占总股本6.66%
证券之星 · 07-30
百洋医药(301015)2名股东合计质押3500万股,占总股本6.66%
百洋医药:公司应收账款主要来源于公立医院,不存在重大风险
证券之星 · 07-26
百洋医药:公司应收账款主要来源于公立医院,不存在重大风险
百洋医药:预计2024年1-6月归属净利润盈利3.6亿元至3.75亿元
证券之星 · 07-25
百洋医药:预计2024年1-6月归属净利润盈利3.6亿元至3.75亿元
百洋医药最新公告:上半年净利润预增19%-24%
证券之星 · 07-25
百洋医药最新公告:上半年净利润预增19%-24%
百洋医药(301015.SZ)发预增,预计半年度净利润3.6亿元至3.75亿元,同比增长19%至24%
智通财经 · 07-25
百洋医药(301015.SZ)发预增,预计半年度净利润3.6亿元至3.75亿元,同比增长19%至24%
【百洋医药(301015.SZ)发预增,预计半年度净利润3.6亿元至3.75亿元,同比增长19%至24%】智通财经APP讯,百洋医药(301015.
智通财经 · 07-25
【百洋医药(301015.SZ)发预增,预计半年度净利润3.6亿元至3.75亿元,同比增长19%至24%】智通财经APP讯,百洋医药(301015.
百洋医药(301015)7月18日主力资金净买入770.49万元
证券之星 · 07-19
百洋医药(301015)7月18日主力资金净买入770.49万元
企查查APP显示近日阿斯利康中金(青岛)创业投资基金合伙企业(有限合伙)成立出资额10亿元经营范围包括:以私募基金从事股权投资、投资管理、资产管理等活动。
智通财经 · 07-18
企查查APP显示近日阿斯利康中金(青岛)创业投资基金合伙企业(有限合伙)成立出资额10亿元经营范围包括:以私募基金从事股权投资、投资管理、资产管理等活动。
百洋医药:公司一直注重不同的价格管控,严格遵照相关政策
证券之星 · 07-05
百洋医药:公司一直注重不同的价格管控,严格遵照相关政策
百洋医药(301015)4.07亿股限售股将于7月3日解禁,占总股本77.38%
证券之星 · 07-03
百洋医药(301015)4.07亿股限售股将于7月3日解禁,占总股本77.38%
【7家公司限售股今日解禁,百洋医药解禁市值超95亿元】 周三,共有7家公司限售股解禁,合计解禁量为5.26亿股,按最新收盘价计算,合计解禁市值为109.
智通财经 · 07-03
【7家公司限售股今日解禁,百洋医药解禁市值超95亿元】 周三,共有7家公司限售股解禁,合计解禁量为5.26亿股,按最新收盘价计算,合计解禁市值为109.
7家公司限售股今日解禁,百洋医药解禁市值超95亿元
界面 · 07-03
7家公司限售股今日解禁,百洋医药解禁市值超95亿元
【读财报】A股7月解禁规模同比下降约18.3% 大全能源、三生国健、百洋医药解禁市值超百亿元
新华财经 · 07-01
【读财报】A股7月解禁规模同比下降约18.3% 大全能源、三生国健、百洋医药解禁市值超百亿元
公司概况
公司名称:
青岛百洋医药股份有限公司
所属行业:
批发业
上市日期:
2021-06-30
主营业务:
青岛百洋医药股份有限公司是专业的医药产品商业化平台,主营业务是为医药产品生产企业提供商业化整体解决方案,包括提供医药产品的品牌运营、批发配送及零售,致力于成为连接医药产品和下游消费者的纽带,为品牌医药生产企业提供产品营销的综合解决方案。
发行价格:
7.64
{"stockData":{"symbol":"301015","market":"SZ","secType":"STK","nameCN":"百洋医药","latestPrice":22.85,"timestamp":1723791816000,"preClose":23.02,"halted":0,"volume":1692100,"delay":0,"floatShares":526000000,"shares":526000000,"eps":1.3316,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.17,"latestTime":"08-16 15:00:00","open":22.93,"high":23.5,"low":22.7,"amount":38706800,"amplitude":0.0348,"askPrice":22.85,"askSize":53,"bidPrice":22.84,"bidSize":20,"shortable":0,"etf":0,"ttmEps":1.3316,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1724031000000},"adr":0,"adjPreClose":23.02,"symbolType":"stock","openAndCloseTimeList":[[1723771800000,1723779000000],[1723784400000,1723791600000]],"highLimit":25.32,"lowLimit":20.72,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":525613491,"pbRate":4.42,"roa":"--","roe":"6.03%","epsLYR":1.25,"committee":-0.16,"marketValue":12010000000,"floatMarketCap":12010000000,"peRate":17.159808,"changeRate":-0.0074,"turnoverRate":0.0032,"status":1},"requestUrl":"/m/hq/s/301015/wiki","defaultTab":"wiki","newsList":[{"id":"2460206223","title":"百洋医药新提交2件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2460206223","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460206223?lang=zh_cn&edition=full","pubTime":"2024-08-17 13:15","pubTimestamp":1723871713,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示,近日青岛百洋医药股份有限公司新提交2件商标注册申请。商标申请详情如下:今年以来青岛百洋医药股份有限公司新申请注册商标32件,截止目前公司共持有注册商标437件,另有45件商标尚在注册申请中。数据来源:企查查以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024081700014404.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301015"],"gpt_icon":0},{"id":"2457970833","title":"百洋医药最新公告:拟5900万元参设廊坊临空百洋股权投资基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2457970833","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457970833?lang=zh_cn&edition=full","pubTime":"2024-08-08 20:11","pubTimestamp":1723119061,"startTime":"0","endTime":"0","summary":"百洋医药公告,公司拟与北京百洋众信康健投资管理有限公司、河北临空私募基金管理有限公司、河北临空产业股权投资基金合伙企业、廊坊市主导产业投资引导基金有限公司共同出资设立廊坊临空百洋股权投资基金合伙企业。该投资基金的认缴出资额为2亿元,公司拟作为有限合伙人认缴出资5900万元,占出资总额的29.5%。另外,公司拟购买控股股东百洋集团持有的北京市门头沟区百洋医药产业投资基金10%的份额,对应认缴出资额2500万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024080800039936.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301015","BK0250"],"gpt_icon":0},{"id":"2457939450","title":"百洋医药(301015.SZ)拟出资5900万元入伙廊坊临空百洋股权投资基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2457939450","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457939450?lang=zh_cn&edition=full","pubTime":"2024-08-08 19:46","pubTimestamp":1723117619,"startTime":"0","endTime":"0","summary":"智通财经APP讯,百洋医药(301015.SZ)公告,公司拟与北京百洋众信康健投资管理有限公司、河北临空私募基金管理有限公司、河北临空产业股权投资基金合伙企业(有限合伙)、廊坊市主导产业投资引导基金有限公司共同出资设立廊坊临空百洋股权投资基金合伙企业(有限合伙)(暂定名)。据悉,该基金的认缴出资额为人民币2亿元,公司拟认缴出资5900万元,占比29.50%。该基金重点投资于创新药和高端医疗器械生产制造、医药和器械等商品的物流配送、供应链、相关产业链技术等领域。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1161846.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0250","301015"],"gpt_icon":0},{"id":"2455902898","title":"华源证券7月31日发布研报称,给予百洋医药(301015.SZ)买入评级。评级理由主要包括:1)迪巧焕发新活力,院外业务潜力可期;","url":"https://stock-news.laohu8.com/highlight/detail?id=2455902898","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455902898?lang=zh_cn&edition=full","pubTime":"2024-07-31 17:44","pubTimestamp":1722419057,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["01477","161027","301015","BK0250","BK1191","BK1574"],"gpt_icon":0},{"id":"2455025839","title":"华源证券:给予百洋医药买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2455025839","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455025839?lang=zh_cn&edition=full","pubTime":"2024-07-31 17:40","pubTimestamp":1722418845,"startTime":"0","endTime":"0","summary":"华源证券股份有限公司刘闯近期对百洋医药进行研究并发布了研究报告《大健康品牌商业化平台,集团孵化+外部合作持续注入增长动能》,本报告对百洋医药给出买入评级,当前股价为22.86元。百洋制药布局中成药及化药业务,资产较为优质,2023年收入和净利润分别为7.6亿元及1.4亿元,近年增速较为稳健。首次覆盖,给予“买入”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024073100038116.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301015","161027"],"gpt_icon":0},{"id":"2455909841","title":"7月31日百洋医药涨6.18%,安信医药健康股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2455909841","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455909841?lang=zh_cn&edition=full","pubTime":"2024-07-31 16:51","pubTimestamp":1722415886,"startTime":"0","endTime":"0","summary":"证券之星消息,7月31日百洋医药涨6.18%,收盘报22.86元,换手率0.54%,成交量2.83万手,成交额6343.17万元。根据2024基金半年报公募基金重仓股数据,重仓该股的公募基金共11家,其中持有数量最多的公募基金为安信医药健康股票A。安信医药健康股票A目前规模为16.61亿元,最新净值0.8381,较上一交易日下跌0.69%,近一年下跌28.32%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024073100034356.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301015","BK0250"],"gpt_icon":0},{"id":"2455098069","title":"百洋医药涨6.18%,天风证券二个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2455098069","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455098069?lang=zh_cn&edition=full","pubTime":"2024-07-31 16:51","pubTimestamp":1722415880,"startTime":"0","endTime":"0","summary":"今日百洋医药涨6.18%,收盘报22.86元。2024年5月7日,天风证券研究员杨松,张雪发布了对百洋医药的研报《业绩符合预期,品牌矩阵持续扩张》,该研报对百洋医药给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算,该研报作者对此股的盈利预测准确度为90.38%。证券之星数据中心计算显示,对该股盈利预测较准的分析师团队为天风证券的杨松。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024073100034350.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601162","301015"],"gpt_icon":0},{"id":"2455460937","title":"百洋医药(301015)2名股东合计质押3500万股,占总股本6.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2455460937","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455460937?lang=zh_cn&edition=full","pubTime":"2024-07-30 21:26","pubTimestamp":1722345973,"startTime":"0","endTime":"0","summary":"证券之星消息,百洋医药7月30日公开信息显示,股东百洋医药集团有限公司、北京百洋诚创医药投资有限公司向云南国际信托有限公司、青岛农村商业银行股份有限公司市北支行合计质押3500.0万股,占总股本6.66%。百洋医药主营业务:为医药产品生产企业提供商业化整体解决方案,包括提供医药产品的品牌运营、批发配送及零售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024073000043115.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301015","BK0250"],"gpt_icon":0},{"id":"2454331828","title":"百洋医药:公司应收账款主要来源于公立医院,不存在重大风险","url":"https://stock-news.laohu8.com/highlight/detail?id=2454331828","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454331828?lang=zh_cn&edition=full","pubTime":"2024-07-26 17:02","pubTimestamp":1721984539,"startTime":"0","endTime":"0","summary":"百洋医药董秘:投资者您好,本次收购前,百洋医药集团有限公司于2021年取得百洋制药控制权,确认商誉10,690.05万元;本次收购为同一控制下的企业合并,除上述商誉外,不会导致公司合并报表新增其他商誉。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072600034763.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301015","BK0250"],"gpt_icon":0},{"id":"2454882221","title":"百洋医药:预计2024年1-6月归属净利润盈利3.6亿元至3.75亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2454882221","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454882221?lang=zh_cn&edition=full","pubTime":"2024-07-25 20:00","pubTimestamp":1721908831,"startTime":"0","endTime":"0","summary":"证券之星消息,百洋医药发布业绩预告,预计2024年1-6月归属净利润盈利3.6亿元至3.75亿元。百洋医药2024年一季报显示,公司主营收入16.61亿元,同比下降1.5%;归母净利润1.66亿元,同比上升35.6%;扣非净利润1.65亿元,同比上升30.71%;负债率50.3%,投资收益842.38万元,财务费用1097.09万元,毛利率29.75%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072500041787.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301015"],"gpt_icon":0},{"id":"2454826465","title":"百洋医药最新公告:上半年净利润预增19%-24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454826465","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454826465?lang=zh_cn&edition=full","pubTime":"2024-07-25 19:00","pubTimestamp":1721905256,"startTime":"0","endTime":"0","summary":"百洋医药公告,预计上半年净利3.599亿元-3.75亿元,同比增长19%-24%。以上内容由证券之星根据公开信息整理,由算法生成(网信算备310104345710301240019号),与本站立场无关,如数据存在问题请联系我们。本文为数据整理,不对您构成任何投资建议,投资有风险,请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024072500038740.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301015"],"gpt_icon":0},{"id":"2454825734","title":"百洋医药(301015.SZ)发预增,预计半年度净利润3.6亿元至3.75亿元,同比增长19%至24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2454825734","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454825734?lang=zh_cn&edition=full","pubTime":"2024-07-25 18:51","pubTimestamp":1721904698,"startTime":"0","endTime":"0","summary":"智通财经APP讯,百洋医药(301015.SZ)披露2024年半年度业绩预告,公司预计归属于上市公司股东的净利润3.6亿元至3.75亿元,同比增长19%至24%;归属于上市公司股东的扣除非经常性损益后的净利润3.59亿元至3.73亿元,同比增长23%至28%。报告期内公司聚焦品牌运营业务,针对患者需求,持续推进产品差异化突破,核心运营品牌迪巧、哈乐、纽特舒玛等收入稳健增长,提升了公司的核心竞争力与经营业绩。报告期内,公司持续加强市场推广工作,提升核心品牌在医院、药店及线上的市场份额。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1155694.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301015"],"gpt_icon":0},{"id":"2454825097","title":"【百洋医药(301015.SZ)发预增,预计半年度净利润3.6亿元至3.75亿元,同比增长19%至24%】智通财经APP讯,百洋医药(301015.","url":"https://stock-news.laohu8.com/highlight/detail?id=2454825097","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2454825097?lang=zh_cn&edition=full","pubTime":"2024-07-25 18:51","pubTimestamp":1721904698,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK0250","301015"],"gpt_icon":0},{"id":"2452346069","title":"百洋医药(301015)7月18日主力资金净买入770.49万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2452346069","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452346069?lang=zh_cn&edition=full","pubTime":"2024-07-19 09:14","pubTimestamp":1721351696,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年7月18日收盘,百洋医药报收于23.08元,上涨2.85%,换手率0.55%,成交量2.89万手,成交额6594.73万元。近5日资金流向一览见下表:百洋医药融资融券信息显示,融资方面,当日融资买入427.23万元,融资偿还182.18万元,融资净买入245.05万元。百洋医药主营业务:为医药产品生产企业提供商业化整体解决方案,包括提供医药产品的品牌运营、批发配送及零售。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024071900014748.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301015"],"gpt_icon":0},{"id":"2452843124","title":"企查查APP显示近日阿斯利康中金(青岛)创业投资基金合伙企业(有限合伙)成立出资额10亿元经营范围包括:以私募基金从事股权投资、投资管理、资产管理等活动。","url":"https://stock-news.laohu8.com/highlight/detail?id=2452843124","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452843124?lang=zh_cn&edition=full","pubTime":"2024-07-18 13:50","pubTimestamp":1721281807,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0320765992.SGD","BK1583","301015","BK1229","BK4588","LU1829250122.USD","LU2236285917.USD","BK4007","09983","BK1542","AZN","BK4568","LU0109394709.USD","BK4585","BK0250","LU0889565916.HKD","BK1258"],"gpt_icon":0},{"id":"2449593862","title":"百洋医药:公司一直注重不同的价格管控,严格遵照相关政策","url":"https://stock-news.laohu8.com/highlight/detail?id=2449593862","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2449593862?lang=zh_cn&edition=full","pubTime":"2024-07-05 17:01","pubTimestamp":1720170118,"startTime":"0","endTime":"0","summary":"投资者:董秘您好,公司收购的百洋制药其主力产品是治疗肝纤维化的扶正化瘀片。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070500033223.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","301015"],"gpt_icon":0},{"id":"2448711116","title":"百洋医药(301015)4.07亿股限售股将于7月3日解禁,占总股本77.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2448711116","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448711116?lang=zh_cn&edition=full","pubTime":"2024-07-03 08:02","pubTimestamp":1719964937,"startTime":"0","endTime":"0","summary":"证券之星消息,根据市场公开信息整理,百洋医药于7月3日将有4.07亿股限售股份解禁,为公司首发原股东限售股份,占公司总股本77.38%。本次解禁后,公司已无限售股份。百洋医药主营业务:为医药产品生产企业提供商业化整体解决方案,包括提供医药产品的品牌运营、批发配送及零售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024070300013851.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301015","BK0250"],"gpt_icon":0},{"id":"2448116355","title":"【7家公司限售股今日解禁,百洋医药解禁市值超95亿元】 周三,共有7家公司限售股解禁,合计解禁量为5.26亿股,按最新收盘价计算,合计解禁市值为109.","url":"https://stock-news.laohu8.com/highlight/detail?id=2448116355","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448116355?lang=zh_cn&edition=full","pubTime":"2024-07-03 07:49","pubTimestamp":1719964151,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=astock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["603990","BK0224","BK0098","BK0116","300162","BK0141","BK0146","BK0231","BK0214","688717","301015","BK0077","BK0250"],"gpt_icon":0},{"id":"2448116867","title":"7家公司限售股今日解禁,百洋医药解禁市值超95亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448116867","media":"界面","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448116867?lang=zh_cn&edition=full","pubTime":"2024-07-03 07:49","pubTimestamp":1719964144,"startTime":"0","endTime":"0","summary":"Wind数据显示,周三(7月3日),共有7家公司限售股解禁,合计解禁量为5.26亿股,按最新收盘价计算,合计解禁市值为109.87亿元。从解禁量来看,4家公司解禁股数超千万股。百洋医药、雷曼光电、麦迪科技解禁量居前,解禁股数分别为4.07亿股、7000.0万股、2787.22万股。从解禁市值来看,4家公司解禁股数超亿元。百洋医药、艾罗能源、雷曼光电解禁市值居前,解禁市值分别为95.46亿元、6.3亿元、4.8亿元。从解禁股数占总股本比例来看,2家公司解禁比例超10%。百洋医药、雷曼光电、麦迪科技解禁比例居前,解禁比例分别为77.38%、16.69%、9.1%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703074904aef7a378&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240703074904aef7a378&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0146","BK0250","603990","301015","BK0231"],"gpt_icon":0},{"id":"2448984928","title":"【读财报】A股7月解禁规模同比下降约18.3% 大全能源、三生国健、百洋医药解禁市值超百亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2448984928","media":"新华财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2448984928?lang=zh_cn&edition=full","pubTime":"2024-07-01 07:25","pubTimestamp":1719789904,"startTime":"0","endTime":"0","summary":"图1:2023年7月至2024年7月限售股解禁规模具体来看,大全能源、三生国健、百洋医药解禁规模位列前三,解禁市值均超百亿元。本轮限售股解禁市值约为111.94亿元,约占总股本比例约为84.96%。7月解禁市值第三大的公司是百洋医药。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407010725369ee8648a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407010725369ee8648a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688336","159982","399300","301015","688303"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2021-06-30","address":"山东省青岛市市北区开封路88号","stockEarnings":[{"period":"1week","weight":-0.0017},{"period":"1month","weight":0.0183},{"period":"3month","weight":-0.2951},{"period":"6month","weight":-0.2521},{"period":"1year","weight":0.0319},{"period":"ytd","weight":-0.3468}],"companyName":"青岛百洋医药股份有限公司","boardCode":"AI0051","perCapita":"71385股","boardName":"批发业","registeredCapital":"52561万元","compareEarnings":[{"period":"1week","weight":0.006},{"period":"1month","weight":-0.0282},{"period":"3month","weight":-0.0871},{"period":"6month","weight":0.0047},{"period":"1year","weight":-0.0899},{"period":"ytd","weight":-0.0321}],"survey":" 青岛百洋医药股份有限公司是专业的医药产品商业化平台,主营业务是为医药产品生产企业提供商业化整体解决方案,包括提供医药产品的品牌运营、批发配送及零售,致力于成为连接医药产品和下游消费者的纽带,为品牌医药生产企业提供产品营销的综合解决方案。","serverTime":1723925452561,"listedPrice":7.64,"stockholders":"7363人(较上一季度减少6.24%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百洋医药(301015)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百洋医药(301015)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百洋医药,301015,百洋医药股票,百洋医药股票老虎,百洋医药股票老虎国际,百洋医药行情,百洋医药股票行情,百洋医药股价,百洋医药股市,百洋医药股票价格,百洋医药股票交易,百洋医药股票购买,百洋医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百洋医药(301015)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百洋医药(301015)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}